Differential metabolic effects of glucosamine and N-acetylglucosamine in human articular chondrocytes

Osteoarthritis and Cartilage

Volumn 17, Issue 8, 2009, Pages 1022-1028

  Shikhman, A R ^a,b   Brinson, D C ^a   Valbracht, J ^a   Lotz, M K ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SCRIPPS CLINIC   (United States)

Author keywords

Chondrocytes; Glucosamine; N acetylglucosamine; Osteoarthritis

Indexed keywords

DEOXYGLUCOSE; GLUCOSAMINE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLYCOSAMINOGLYCAN POLYSULFATE; HYALURONIC ACID; N ACETYLGLUCOSAMINE;

ARTICLE; CARBOHYDRATE SYNTHESIS; CARTILAGE CELL; CELL ISOLATION; CELL TYPE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; UPREGULATION; WESTERN BLOTTING;

CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; FUCOSE; GLUCOSAMINE; HUMANS; IMMUNOHISTOCHEMISTRY; KNEE JOINT; OSTEOARTHRITIS;

EID: 67650447965     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2009.03.004     Document Type: Article

References (43)

1. Dieppe P., Chard J., Lohmnader S., and Smith C. Osteoarthritis. Clin Evid 7 (2002) 1071-90
2. Reginster J.Y. The prevalence and burden of arthritis. Rheumatology (Oxford) 41 (2002) 3-6
3. Goldberg S.H., Von Feldt J.M., and Lonner J.H. Pharmacologic therapy for osteoarthritis. Am J Orthop 31 (2002) 673-680
4. Rubin B.R., Talent J.M., Kongtawelert P., Pertusi R.M., Forman M.D., and Gracy R.W. Oral polymeric N-acetyl-d-glucosamine and osteoarthritis. J Am Osteopath Assoc 101 (2001) 339-344
5. Christgau S., Henrotin Y., Tanko L.B., Rovati L.C., Collette J., Bruyere O., et al. Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate. Clin Exp Rheumatol 22 (2004) 36-42
6. Hughes R., and Carr A. A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee. Rheumatology (Oxford) 41 (2002) 279-284
7. Pavelka K., Gatterova J., Olejarova M., Machacek S., Giacovelli G., and Rovati L.C. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 162 (2002) 2113-2123
8. Reginster J.Y., Deroisy R., Rovati L.C., Lee R.L., Lejeune E., Bruyere O., et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 357 (2001) 251-256
9. Shikhman A.R., Amiel D., D'Lima D., Hwang S.B., Hu C., Xu A., et al. Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis. Ann Rheum Dis 64 (2005) 89-94
10. Uldry M., Ibberson M., Hosokawa M., and Thorens B. GLUT2 is a high affinity glucosamine transporter. FEBS Lett 524 (2002) 199-203
11. Richardson S., Neama G., Phillips T., Bell S., Carter S.D., Moley K.H., et al. Molecular characterization and partial cDNA cloning of facilitative glucose transporters expressed in human articular chondrocytes; stimulation of 2-deoxyglucose uptake by IGF-I and elevated MMP-2 secretion by glucose deprivation. Osteoarthritis Cartilage 11 (2003) 92-101
12. Shikhman A.R., Brinson D.C., Valbracht J., and Lotz M.K. Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J Immunol 167 (2001) 7001-7008
13. Shikhman A.R., Brinson D.C., and Lotz M.K. Distinct pathways regulate facilitated glucose transport in human articular chondrocytes during anabolic and catabolic responses. Am J Physiol Endocrinol Metab 286 (2004) E980-E985
14. Otte P. Basic cell metabolism of articular cartilage: manometric studies. Z Rheumatol 50 (1991) 304-312
15. Lee R.B., and Urban J.P. Evidence for a negative Pasteur effect in articular cartilage. Biochem J 321 (1997) 95-102
16. Kim J.J., and Conrad H.E. Kinetics of mucopolysaccharide and glycoprotein synthesis by chick embryo chondrocytes: effect of d-glucose concentration in the culture medium. J Biol Chem 251 (1976) 6210-6217
17. Sweeney C., Mackintosh D., and Mason R.M. UDP-sugar metabolism in Swarm rat chondrosarcoma chondrocytes. Biochem J 290 (1993) 563-570
18. Mankin H.J., Dorfman H., Lippielo L., and Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 53 (1971) 523-537
19. Hresko R.C., Heimberg H., Chi M.M., and Mueckler M. Glucosamine-induced insulin resistance in 3T3-L1 adipocytes is caused by depletion of intracellular ATP. J Biol Chem 273 (1998) 20658-20668
20. Liu J., Shikhman A.R., Lotz M.K., and Wong C.H. Hesoxaminidase inhibitors as new drug candidates for the therapy of osteoarthritis. Chem Biol 8 (2001) 701-711
21. Mason R.M., and Sweeney C. The relationship between proteoglycan synthesis in Swarm chondrocytes and pathways of cellular energy and UDP-sugar metabolism. Carbohydr Res 255 (1994) 255-270
22. Nelson B.A., Robinson K.A., and Buse M.G. High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes 49 (2000) 981-991
23. Bosch R.R., Bazuine M., Wake M.M., Span P.N., Olthaar A.J., Schurmann A., et al. Inhibition of protein kinase C beta II increases glucose uptake in 3T3-L1 adipocytes through elevated expression of glucose transporter 1 at the plasma membrane. Mol Endocrinol 17 (2003) 1230-1239
24. Von der Crone S., Deppe C., Barthel A., Sasson S., Joost H.G., and Schurmann A. Glucose deprivation induces Akt-dependent synthesis and incorporation of GLUT1, but not of GLUT4, into the plasma membrane of 3T3-L1 adipocytes. Eur J Cell Biol 79 (2000) 943-949
25. Samih N., Hovsepian S., Notel F., Prorok M., Zattara-Cannoni H., Mathieu S., et al. The impact of N- and O-glycosylation on the functions of Glut-1 transporter in human thyroid anaplastic cells. Biochim Biophys Acta 1621 (2003) 92-101
26. Somwar R., Koterski S., Sweeney G., Sciotti R., Djuric S., Berg C., et al. A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation. J Biol Chem 277 (2002) 50386-50395
27. Cuenda A., and Alessi D.R. Use of kinase inhibitors to dissect signaling pathways. Methods Mol Biol 99 (2000) 161-175
28. Konrad R.J., Zhang F., Hale J.E., Knierman M.D., Becker G.W., and Kudlow J.E. Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. Biochem Biophys Res Commun 293 (2002) 207-212
29. McDonald J.A., and Camenisch T.D. Hyaluronan: genetic insights into the complex biology of a simple polysaccharide. Glycoconj J 19 (2002) 331-339
30. Tan C.H., Peterson N.A., and Raghupathy E. Characteristics of d-glucosamine uptake by rat brain synaptosomes. J Neurochem 29 (1977) 261-265
31. Baron A.D., Zhu J.S., Zhu J.H., Weldon H., Maianu L., and Garvey W.T. Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity. J Clin Invest 96 (1995) 2792-2801
32. Rajpurohit R., Koch C.J., Tao Z., Teixeira C.M., and Shapiro I.M. Adaptation of chondrocytes to low oxygen tension: relationship between hypoxia and cellular metabolism. J Cell Physiol 168 (1996) 424-432
33. Stockwell R.A. Metabolism of cartilage. In: Hall B.K. (Ed). Cartilage: Structure, Function and Biochemistry (1983), Academic Press 253-280
34. Qu C.J., Karjalainen H.M., Helminen H.J., and Lammi M.J. The lack of effect of glucosamine sulphate on aggrecan mRNA expression and (35)S-sulphate incorporation in bovine primary chondrocytes. Biochim Biophys Acta (1762) 453-459
35. Qu C.J., Jauhiainen M., Auriola S., Helminen H.J., and Lammi M.J. Effects of glucosamine sulfate on intracellular UDP-hexosamine and UDP-glucuronic acid levels in bovine primary chondrocytes. Osteoarthritis Cartilage 15 (2007) 773-779
36. Kleine T.O., and Stephan R. Biosynthesis of chondroitin sulfate side chains and hyaluronate. Time-course studies with cartilage slices of calf ribs under different conditions. Biochim Biophys Acta 451 (1976) 444-456
37. Noyszewski E.A., Wroblewski K., Dodge G.R., Kudchodkar S., Beers J., Sarma A.V., et al. Preferential incorporation of glucosamine into the galactosamine moieties of chondroitin sulfates in articular cartilage explants. Arthritis Rheum 44 (2001) 1089-1095
38. Bassleer C., Rovati L., and Franchimont P. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage 6 (1998) 427-434
39. Mroz P.J., and Silbert J.E. Effects of [3H]glucosamine concentration on [3H]chondroitin sulphate formation by cultured chondrocytes. Biochem J 376 (2003) 511-515
40. De Mattei M., Pellati A., Pasello M., de Terlizzi F., Massari L., Gemmati D., et al. High doses of glucosamine-HCl have detrimental effects on bovine articular cartilage explants cultured in vitro. Osteoarthritis Cartilage 10 (2002) 816-825
41. Parri M.E., Virkamaki A., Landaker E.J., Kahn C.R., and Yki-Jarvinen H. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes 48 (1999) 1562-1571
42. Filippis A., Clark S., and Proietto J. Increased flux through the hexosamine biosynthesis pathway inhibits glucose transport acutely by activation of protein kinase C. Biochem J 324 (1997) 981-985
43. Biggee B.A., Blinn C.M., McAlindon T.E., Nuite M., and Silbert J.E. Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness. Ann Rheum Dis 65 (2006) 222-226